drugset / Trial / NCT04489797
A Study to Evaluate Effects of Proton-pump Inhibitor on Acalabrutinib Capsule When Administered Orally With COCA-COLA in Healthy Participants
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is being conducted to support the clinical development of acalabrutinib in participants who need treatment with proton pump inhibitors while taking acalabrutinib.
Timeline
- Start
- 2020-07-20
- Primary completion
- 2020-08-28
- Completion
- 2020-08-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acalabrutinib | Small molecule | 100 mg | Oral |
| Subject | Rabeprazole | Small molecule | 20 mg | Oral |